亞太地區全基因組和EXOME定序市場（按最終用戶和國家分類）-分析和預測（2024-2033）

亞太地區全基因組和EXOME定序市場規模預計將從 2024 年的 4.259 億美元增至 2033 年的 17.848 億美元，2024-2033 年預測期內的複合年成長率為 15.13%。

WGS 分析整個基因組，而 WES 則專注於蛋白質轉錄區，其中包含大多數與疾病相關的變異。隨著成本下降和應用範圍擴大，這些技術正變得越來越普遍。

由於基因組學的進步、遺傳患者病率的上升以及精準醫療的投資不斷增加，亞太地區的全基因組和EXOME定序市場正在迅速擴張。臨床診斷、個人化治療和生物醫學研究都依賴全基因組定序（WGS），它梳理一個人的 DNA，以及全EXOME定序（WES），專注於蛋白質編碼區域。

由於政府的強力舉措、生物技術產業的不斷發展以及醫療保健提供者和研究機構之間日益加強的夥伴關係，中國、日本、韓國和印度等國家正在引領這一市場。由於定序技術成本的下降以及巨量資料分析和人工智慧（AI）的使用，市場正在不斷擴大。

生殖醫學、藥物基因體學、腫瘤學和罕見疾病診斷是主要應用領域。直接面對消費者（DTC）檢測服務的興起和人們對基因檢測的認知不斷提高也推動了市場需求。但資料隱私、複雜法規和道德困境等問題仍然存在。

考慮到這些，由於技術進步、醫療保健成本上升以及對精準和資料驅動的醫療解決方案的需求不斷增加，亞太地區的全基因組和EXOME定序市場預計將大幅成長。

本報告研究了亞太地區的全基因組和EXOME定序市場，提供了市場概況以及最終用戶和特定國家的趨勢以及參與市場的公司概況。

目錄

執行摘要

第1章 產業展望

• 市場趨勢
• COVID-19 市場影響
• 法律規範
• 供應鏈分析
• 市場動態概覽

第2章 區域

• 區域概況
• 亞太地區

第3章 市場競爭基準化分析與公司概況

• 關鍵策略和發展
• 公司簡介
  • BGI Group (Beijing Genomics Institute (BGI))
  • Novogene Corporation

第4章調查方法

Introduction to Asia-Pacific Whole Genome and Exome Sequencing Market

The Asia-Pacific whole genome and exome sequencing market is projected to reach $1,784.8 million by 2033 from $425.9 million in 2024, growing at a CAGR of 15.13% during the forecast period 2024-2033. WGS analyses the entire genome, whereas WES concentrates on protein-coding regions that contain the majority of disease-related variants. As costs come down and applications increase, these technologies are becoming more and more popular.

Market Introduction

The market for whole genome and exome sequencing in Asia-Pacific (APAC) is expanding quickly due to advances in genomics, an increase in the prevalence of genetic disorders, and growing investments in precision medicine. Clinical diagnostics, customised treatments, and biomedical research all depend on whole genome sequencing (WGS), which offers a thorough examination of a person's DNA, and whole exome sequencing (WES), which concentrates on protein-coding regions.

With robust government initiatives, growing biotechnology sectors, and growing partnerships between healthcare providers and research institutions, nations like China, Japan, South Korea, and India are leading this market. The market is expanding due to the declining cost of sequencing technologies, as well as the use of big data analytics and artificial intelligence (AI).

Reproductive health, pharmacogenomics, oncology, and rare disease diagnosis are important applications. Demand in the market is also being influenced by the rise of direct-to-consumer (DTC) testing services and increased awareness of genetic testing. But there are still issues like data privacy, complicated regulations, and moral dilemmas.

All things considered, the APAC whole genome and exome sequencing market is expected to grow significantly due to advancements in technology, rising healthcare costs, and the growing demand for accurate, data-driven medical solutions.

Market Segmentation:

Segmentation 1: by End User

• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Hospitals and Clinics
• Research and Academic Institutes
• Others

Segmentation 2: by Country

• Japan
• India
• China
• Singapore
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in genome and exome sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• BGI Group
• Novogene Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Industry Outlook

• 1.1 Market Trends
  • 1.1.1 Technological Innovations in the Sequencing Technology
  • 1.1.2 Numerous Inorganic Growth Activities in the Market
• 1.2 COVID-19 Impact on Market
• 1.3 Regulatory Framework
  • 1.3.1 Legal Requirements and Framework in Japan
• 1.4 Supply Chain Analysis
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Growing Applications of Whole Genome and Exome Sequencing in Clinical Diagnostics
    • 1.5.1.2 Rising Demand for Personalized Medicine Influencing the Demand for Whole Genome and Exome Sequencing
    • 1.5.1.3 Lowering Costs and Increasing Accessibility of Genome Sequencing
    • 1.5.1.4 Ongoing Whole Genome Sequencing Government Initiatives around the World
  • 1.5.2 Market Restraints
    • 1.5.2.1 Privacy and Ethical Concerns due to Increased Risk of Security Breaches
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Increasing Usage of Sequencing Technology in Emerging Markets

2 Region

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
    • 2.2.3.1 By End User
  • 2.2.4 China
  • 2.2.5 India
  • 2.2.6 Australia
  • 2.2.7 Japan
  • 2.2.8 Singapore
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Key Strategies and Development
• 3.2 Company Profiles
  • 3.2.1 BGI Group (Beijing Genomics Institute (BGI))
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Key Personnel
    • 3.2.1.5 Analyst View
  • 3.2.2 Novogene Corporation
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products/Product Portfolio
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Key Personnel
    • 3.2.2.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023, 2026, and 2033
• Figure 2: Key Events to Keep Track of within the Whole Genome and Exome Sequencing Market
• Figure 3: Value and Supply Chain Analysis, Whole Genome and Exome Sequencing Market
• Figure 4: Analysis of Market Navigating Factors, 2023-2033
• Figure 5: Key Clinical Applications of Whole Genome and Whole Exome Sequencing
• Figure 6: Number of Research Papers Mentioning Personalized Medicine in PubMed, 2010-2023
• Figure 7: Decreasing Genome Sequencing Costs
• Figure 8: Map of a Few Recent and Ongoing Government-Funded National Genomic-Medicine Initiatives
• Figure 9: Examples of Security Breaches in Whole Genome and Exome Sequencing
• Figure 10: China Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 11: India Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 12: Australia Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 13: Japan Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 14: Singapore Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 15: Rest-of-Asia-Pacific Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 16: Strategic Initiatives, January 2021-April 2024
• Figure 17: Share of Strategic Initiatives, January 2021-April 2024
• Figure 18: Data Triangulation
• Figure 19: Top-Down and Bottom-Up Approach
• Figure 20: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Recent Technological Innovations
• Table 4: Few Major Inorganic Growth Activities in the Whole Genome and Exome Sequencing Market
• Table 5: Whole Genome and Exome Sequencing Market (by Region), $Million, 2023-2033
• Table 6: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033